BioLight Life Sciences Ltd. Ordinary Shares (BOLT)

5.60
0.00 (0.00)
NASDAQ
Prev Close 5.60
Open 5.60
Day Low/High 5.60 / 5.60
52 Wk Low/High /
Exchange NASDAQ
Shares Outstanding 176.45B
Div & Yield N.A. (N.A)

Latest News

BioLight Obtains EU CE Mark For CellDetect® Non-Invasive Test For Detecting Recurrence Of Bladder Cancer

BioLight Obtains EU CE Mark For CellDetect® Non-Invasive Test For Detecting Recurrence Of Bladder Cancer

Core European Patent Granted For CellDetect®

BioLight Announces Strategic Partnership To Significantly Expand Presence In China

BioLight Announces Strategic Partnership To Significantly Expand Presence In China

Hong Kong-based Rock-One International Holdings Ltd to Invest $6.2M in BioLight

BioLight Reports Successful Clinical Study Results For Monitoring Bladder Cancer Recurrence With The CellDetect® Non-Invasive Test

BioLight Reports Successful Clinical Study Results For Monitoring Bladder Cancer Recurrence With The CellDetect® Non-Invasive Test

- Plans to Secure CE Mark for a European Launch of the Non-Invasive Test and Submit a Pre-IDE to the U.S. FDA in 2015 -

BioLight Reports Positive Clinical Study Findings For Its TeaRx™ Diagnostic Parameters For Dry Eye Syndrome

BioLight Reports Positive Clinical Study Findings For Its TeaRx™ Diagnostic Parameters For Dry Eye Syndrome

Positive statistical correlations were identified between TeaRx™ diagnostic parameters and widely used benchmark tests for dry eye syndrome

BioLight Announces IOPtiMate™ Distribution Agreement In Hong Kong And Macao

BioLight Announces IOPtiMate™ Distribution Agreement In Hong Kong And Macao

Receives commitment to purchase at least 9 systems in first 3 years